LifeStance Health Group Inc

For the period ended Dec 31, 2024. Filed Feb 27, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 27, 2025

LFST$14.56-0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations and Comprehensive Loss

(In thousands, except for Net Loss per Share)

	Year Ended December 31,
	2024	2023	2022
TOTAL REVENUE	$1,250,970	$1,055,665	$859,542
OPERATING EXPENSES
Center costs, excluding depreciation and amortization shown separately below	848,571	753,569	622,525
General and administrative expenses	363,062	410,793	377,993
Depreciation and amortization	70,950	80,437	69,198
Total operating expenses	$1,282,583	$1,244,799	$1,069,716
LOSS FROM OPERATIONS	$(31,613)	$(189,134)	$(210,174)
OTHER EXPENSE
Gain (loss) on remeasurement of contingent consideration	1,725	3,972	(1,688)
Transaction costs	(827)	(89)	(722)
Interest expense, net	(26,535)	(21,220)	(19,928)
Other expense	(363)	(112)	(218)
Total other expense	$(26,000)	$(17,449)	$(22,556)
LOSS BEFORE INCOME TAXES	(57,613)	(206,583)	(232,730)
INCOME TAX BENEFIT	170	20,321	17,166
NET LOSS	$(57,443)	$(186,262)	$(215,564)
NET LOSS PER SHARE, BASIC AND DILUTED	(0.15)	(0.51)	(0.61)
Weighted-average shares used to compute basic and diluted net loss per share	379,147	367,457	355,278
NET LOSS	$(57,443)	$(186,262)	$(215,564)
OTHER COMPREHENSIVE (LOSS) INCOME
Unrealized (losses) gains on cash flow hedge, net of tax	(1,374)	(971)	3,274
COMPREHENSIVE LOSS	$(58,817)	$(187,233)	$(212,290)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.